Learn more

VETOQUINOL SA

Overview
  • Total Patents
    117
  • GoodIP Patent Rank
    59,070
  • Filing trend
    ⇩ 55.0%
About

VETOQUINOL SA has a total of 117 patent applications. It decreased the IP activity by 55.0%. Its first patent ever was published in 1977. It filed its patents most often in EPO (European Patent Office), France and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are 3B PHARMACEUTICALS GMBH, HANMI PHARM IND CO LTD and ASIERIS PHARMACEUTICAL TECH CO LTD.

Patent filings per year

Chart showing VETOQUINOL SAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Moreau Marinette 44
#2 Giethlen Bruno 26
#3 Ciapetti Paola 26
#4 Ropp Sandrine 26
#5 Schneider Marc 25
#6 Leblanc Francoise 25
#7 Morice Christophe 25
#8 Wermuth Camille G 24
#9 Chery-Mozziconacci Florence 24
#10 Lego Elodie 12

Latest patents

Publication Filing date Title
WO2021028479A1 Compositions comprising tigolaner for controlling parasites
WO2019068989A1 Appetising composition comprising hydrolysed alpha-s1-casein
FR3077984A1 MULTI-PURPOSE COMPOSITION OF TORASEMIDE
CA3040823A1 Modified antibody constant region
AU2017207533A1 Biophotonic compositions for the treatment of otitis externa
FR3041534A1 ATRIAL CLEANER COMPOSITION
TW200944532A Novel 7-substituted 3-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials
FR2940910A1 New s-adenosyl-methionine compressor
EP2145891A1 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials
CA2600178A1 Novel method for obtaining a fast-dissolving imidapril powder
WO2006059009A1 Novel pharmaceutical composition useful for vaccines
US6180678B1 Use of adrafinil to treat behavioral problems in aged canines
JPH11171783A Oral administration of bacteria at concentration that causes cell-mediated immunity and body weight increase in specific animal
FR2764506A1 Therapeutic or hygienic composition with controlled release and prolonged active ingredient (s), especially for ophthalmic use
FR2760640A1 Use of a pasteurella haemolytica serotype a6 strain for the preparation of a vaccine against bovine pasteurellosis due to pasteurella haemolytica
US5773021A Bioadhesive ophthalmic insert
FR2748934A1 System for the controlled release of a substance soluble in a surrounding liquid, non-woven membrane for the production of such a system and method for obtaining such a membrane
CA2119109A1 Bioadhesive ophthalmic insert
FR2712807A1 Solid mucoadhesive, therapeutic or hygienic composition, for administration by application to the oral or nasal mucosa.
FR2707653A1 Conjugate between a biocompatible and biodegradable polymer and a molecule in particular a biologically active molecule, with mobile hydrogen, its preparation process and pharmaceutical composition comprising this conjugate.